Biological and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Read more
9,586 registered articles
(updated on September 20, 2018)
Online ISSN : 1347-5215
Print ISSN : 0918-6158
Featured article
Volume 41 (2018) Issue 9 Pages 1456-1462
Effects of Supplementary Seleno-L-methionine on Atopic Dermatitis-Like Skin Lesions in Mice Read more
Editor’s picks

Seleno-L-methionine (SeMet) is a major form of selenium compounds in foods. The article by Arakawa et al. demonstrated that ear thickness was increased by repeated application of 2,4,6-trinitrochlorobenzene (TNCB) to the ear, and SeMet significantly suppressed ear thickness in mice. SeMet inhibited epidermal hyperplasia and dense infiltration of inflammatory cells. Serum total immunoglobulin (Ig) E levels were suppressed by SeMet. Interleukin (IL) 4 expression in the ear and superficial parotid lymph node was inhibited by SeMet. These results demonstrated that SeMet suppresses atopic dermatitis-like skin lesions and inhibits the expression of total IgE and IL-4.

View the past featured articles
View all articles in Current issue
Most viewed articles Aug.2018
Share this page
Select past volume & issue
Journal news & Announcements
  • Biol. Pharm. Bull. Vol. 41 No. 9
    Current Topics: Recent Advances in Research on Biological Membranes That Regulate the Central Nervous System

  • Biol. Pharm. Bull. Vol. 41 No. 8
    Current Topics: Ion Channels as Therapeutic Targets for the Immune, Inflammatory, and Metabolic Disorders

  • Biol. Pharm. Bull. Vol. 41 No. 7
    Current Topics:New Insights into Neurozinc and Metallothioneins

  • Biol. Pharm. Bull. Vol. 41 No. 3
    Current Topics: Cutting-Edge Studies Using Artificial Membranes
  • Biol. Pharm. Bull. Vol. 40 No. 12
    Current Topics: Recent Progress in the Study of Vasoactive Modulators in Metabolic and Cardiovascular Diseases